WEBVTT
Kind: captions
Language: en

00:00:00.000 --> 00:00:04.820
 
Oh

00:00:04.820 --> 00:00:04.830
 
 

00:00:04.830 --> 00:00:07.099
 
well in industrialized countries there's

00:00:07.099 --> 00:00:07.109
well in industrialized countries there's
 

00:00:07.109 --> 00:00:09.860
well in industrialized countries there's
no question that the encroachment of the

00:00:09.860 --> 00:00:09.870
no question that the encroachment of the
 

00:00:09.870 --> 00:00:11.570
no question that the encroachment of the
pharmaceutical industry and its

00:00:11.570 --> 00:00:11.580
pharmaceutical industry and its
 

00:00:11.580 --> 00:00:14.450
pharmaceutical industry and its
marketing practices has I think dilla t

00:00:14.450 --> 00:00:14.460
marketing practices has I think dilla t
 

00:00:14.460 --> 00:00:17.300
marketing practices has I think dilla t
really affected the kind of medical care

00:00:17.300 --> 00:00:17.310
really affected the kind of medical care
 

00:00:17.310 --> 00:00:19.670
really affected the kind of medical care
we get and the decisions that consumers

00:00:19.670 --> 00:00:19.680
we get and the decisions that consumers
 

00:00:19.680 --> 00:00:21.590
we get and the decisions that consumers
are making many countries Donal eyes

00:00:21.590 --> 00:00:21.600
are making many countries Donal eyes
 

00:00:21.600 --> 00:00:23.210
are making many countries Donal eyes
something we call DTC or

00:00:23.210 --> 00:00:23.220
something we call DTC or
 

00:00:23.220 --> 00:00:24.980
something we call DTC or
direct-to-consumer advertising the

00:00:24.980 --> 00:00:24.990
direct-to-consumer advertising the
 

00:00:24.990 --> 00:00:27.769
direct-to-consumer advertising the
United States does and what's happened

00:00:27.769 --> 00:00:27.779
United States does and what's happened
 

00:00:27.779 --> 00:00:30.019
United States does and what's happened
is that the pharmaceutical industry can

00:00:30.019 --> 00:00:30.029
is that the pharmaceutical industry can
 

00:00:30.029 --> 00:00:31.669
is that the pharmaceutical industry can
directly market its products to

00:00:31.669 --> 00:00:31.679
directly market its products to
 

00:00:31.679 --> 00:00:36.170
directly market its products to
consumers in until late 1990s the

00:00:36.170 --> 00:00:36.180
consumers in until late 1990s the
 

00:00:36.180 --> 00:00:38.079
consumers in until late 1990s the
pharmaceutical industry could only

00:00:38.079 --> 00:00:38.089
pharmaceutical industry could only
 

00:00:38.089 --> 00:00:41.990
pharmaceutical industry could only
market prescription drugs to healthcare

00:00:41.990 --> 00:00:42.000
market prescription drugs to healthcare
 

00:00:42.000 --> 00:00:44.000
market prescription drugs to healthcare
workers to physicians and then there was

00:00:44.000 --> 00:00:44.010
workers to physicians and then there was
 

00:00:44.010 --> 00:00:46.189
workers to physicians and then there was
a relaxing of those rules and they could

00:00:46.189 --> 00:00:46.199
a relaxing of those rules and they could
 

00:00:46.199 --> 00:00:47.660
a relaxing of those rules and they could
market their product directly to

00:00:47.660 --> 00:00:47.670
market their product directly to
 

00:00:47.670 --> 00:00:50.600
market their product directly to
consumers creating this clamor for the

00:00:50.600 --> 00:00:50.610
consumers creating this clamor for the
 

00:00:50.610 --> 00:00:52.789
consumers creating this clamor for the
latest brand name product which might

00:00:52.789 --> 00:00:52.799
latest brand name product which might
 

00:00:52.799 --> 00:00:54.979
latest brand name product which might
not even necessarily be better or safer

00:00:54.979 --> 00:00:54.989
not even necessarily be better or safer
 

00:00:54.989 --> 00:00:57.049
not even necessarily be better or safer
than the existing product on the market

00:00:57.049 --> 00:00:57.059
than the existing product on the market
 

00:00:57.059 --> 00:01:00.140
than the existing product on the market
what we see to is that because rd is so

00:01:00.140 --> 00:01:00.150
what we see to is that because rd is so
 

00:01:00.150 --> 00:01:01.549
what we see to is that because rd is so
expensive there are a whole bunch of

00:01:01.549 --> 00:01:01.559
expensive there are a whole bunch of
 

00:01:01.559 --> 00:01:02.780
expensive there are a whole bunch of
knee to drugs and that the

00:01:02.780 --> 00:01:02.790
knee to drugs and that the
 

00:01:02.790 --> 00:01:04.219
knee to drugs and that the
pharmaceutical industry is largely

00:01:04.219 --> 00:01:04.229
pharmaceutical industry is largely
 

00:01:04.229 --> 00:01:07.070
pharmaceutical industry is largely
engaged in producing drugs that will

00:01:07.070 --> 00:01:07.080
engaged in producing drugs that will
 

00:01:07.080 --> 00:01:09.590
engaged in producing drugs that will
come on the market to deal with the fact

00:01:09.590 --> 00:01:09.600
come on the market to deal with the fact
 

00:01:09.600 --> 00:01:11.240
come on the market to deal with the fact
that something's off patent it's going

00:01:11.240 --> 00:01:11.250
that something's off patent it's going
 

00:01:11.250 --> 00:01:12.860
that something's off patent it's going
to be cheap because it'll be generic so

00:01:12.860 --> 00:01:12.870
to be cheap because it'll be generic so
 

00:01:12.870 --> 00:01:14.090
to be cheap because it'll be generic so
we need something new and different

00:01:14.090 --> 00:01:14.100
we need something new and different
 

00:01:14.100 --> 00:01:16.880
we need something new and different
maybe minuscule e different from a

00:01:16.880 --> 00:01:16.890
maybe minuscule e different from a
 

00:01:16.890 --> 00:01:19.010
maybe minuscule e different from a
previous drug and I think the story of

00:01:19.010 --> 00:01:19.020
previous drug and I think the story of
 

00:01:19.020 --> 00:01:20.870
previous drug and I think the story of
prilosec and nexium is probably one of

00:01:20.870 --> 00:01:20.880
prilosec and nexium is probably one of
 

00:01:20.880 --> 00:01:22.340
prilosec and nexium is probably one of
the best stories you can tell about a

00:01:22.340 --> 00:01:22.350
the best stories you can tell about a
 

00:01:22.350 --> 00:01:25.040
the best stories you can tell about a
product that comes on the market really

00:01:25.040 --> 00:01:25.050
product that comes on the market really
 

00:01:25.050 --> 00:01:27.470
product that comes on the market really
not any markedly different from the

00:01:27.470 --> 00:01:27.480
not any markedly different from the
 

00:01:27.480 --> 00:01:31.730
not any markedly different from the
first product but they can be sold at 10

00:01:31.730 --> 00:01:31.740
first product but they can be sold at 10
 

00:01:31.740 --> 00:01:34.100
first product but they can be sold at 10
times the cost of the first product

00:01:34.100 --> 00:01:34.110
times the cost of the first product
 

00:01:34.110 --> 00:01:36.350
times the cost of the first product
sometimes more then you've got the issue

00:01:36.350 --> 00:01:36.360
sometimes more then you've got the issue
 

00:01:36.360 --> 00:01:38.000
sometimes more then you've got the issue
of whether or not you control

00:01:38.000 --> 00:01:38.010
of whether or not you control
 

00:01:38.010 --> 00:01:39.800
of whether or not you control
pharmaceutical pricing that's a huge

00:01:39.800 --> 00:01:39.810
pharmaceutical pricing that's a huge
 

00:01:39.810 --> 00:01:41.810
pharmaceutical pricing that's a huge
problem in terms of access to medicines

00:01:41.810 --> 00:01:41.820
problem in terms of access to medicines
 

00:01:41.820 --> 00:01:44.480
problem in terms of access to medicines
that we do need access to and in many

00:01:44.480 --> 00:01:44.490
that we do need access to and in many
 

00:01:44.490 --> 00:01:46.970
that we do need access to and in many
countries there are government controls

00:01:46.970 --> 00:01:46.980
countries there are government controls
 

00:01:46.980 --> 00:01:48.710
countries there are government controls
over pharmaceutical pricing but in the

00:01:48.710 --> 00:01:48.720
over pharmaceutical pricing but in the
 

00:01:48.720 --> 00:01:50.420
over pharmaceutical pricing but in the
United States the drug industry's Lobby

00:01:50.420 --> 00:01:50.430
United States the drug industry's Lobby
 

00:01:50.430 --> 00:01:52.760
United States the drug industry's Lobby
has been so powerful that we don't see

00:01:52.760 --> 00:01:52.770
has been so powerful that we don't see
 

00:01:52.770 --> 00:01:55.010
has been so powerful that we don't see
those same controls over drug company

00:01:55.010 --> 00:01:55.020
those same controls over drug company
 

00:01:55.020 --> 00:01:57.280
those same controls over drug company
pricing we've had some efforts the VA

00:01:57.280 --> 00:01:57.290
pricing we've had some efforts the VA
 

00:01:57.290 --> 00:01:59.120
pricing we've had some efforts the VA
administration of course is one place

00:01:59.120 --> 00:01:59.130
administration of course is one place
 

00:01:59.130 --> 00:02:01.340
administration of course is one place
where we're able to see some measure of

00:02:01.340 --> 00:02:01.350
where we're able to see some measure of
 

00:02:01.350 --> 00:02:03.380
where we're able to see some measure of
control over the pricing of drugs and

00:02:03.380 --> 00:02:03.390
control over the pricing of drugs and
 

00:02:03.390 --> 00:02:05.060
control over the pricing of drugs and
the VA system actually is one of the

00:02:05.060 --> 00:02:05.070
the VA system actually is one of the
 

00:02:05.070 --> 00:02:06.500
the VA system actually is one of the
best systems that functions in our

00:02:06.500 --> 00:02:06.510
best systems that functions in our
 

00:02:06.510 --> 00:02:11.250
best systems that functions in our
country today

00:02:11.250 --> 00:02:11.260
 
 

00:02:11.260 --> 00:02:14.130
 
we'll all of our materials emphasize for

00:02:14.130 --> 00:02:14.140
we'll all of our materials emphasize for
 

00:02:14.140 --> 00:02:16.920
we'll all of our materials emphasize for
women the fact that commercial interests

00:02:16.920 --> 00:02:16.930
women the fact that commercial interests
 

00:02:16.930 --> 00:02:19.110
women the fact that commercial interests
are producing much of the written

00:02:19.110 --> 00:02:19.120
are producing much of the written
 

00:02:19.120 --> 00:02:21.869
are producing much of the written
material the electronic material the TV

00:02:21.869 --> 00:02:21.879
material the electronic material the TV
 

00:02:21.879 --> 00:02:24.569
material the electronic material the TV
shows that they see now that they can't

00:02:24.569 --> 00:02:24.579
shows that they see now that they can't
 

00:02:24.579 --> 00:02:26.970
shows that they see now that they can't
assume that they're getting unbiased

00:02:26.970 --> 00:02:26.980
assume that they're getting unbiased
 

00:02:26.980 --> 00:02:29.369
assume that they're getting unbiased
uncompromised information that conflicts

00:02:29.369 --> 00:02:29.379
uncompromised information that conflicts
 

00:02:29.379 --> 00:02:32.069
uncompromised information that conflicts
of interest exists everywhere so we say

00:02:32.069 --> 00:02:32.079
of interest exists everywhere so we say
 

00:02:32.079 --> 00:02:34.410
of interest exists everywhere so we say
learn the source of your information is

00:02:34.410 --> 00:02:34.420
learn the source of your information is
 

00:02:34.420 --> 00:02:36.720
learn the source of your information is
it a drug company producing the material

00:02:36.720 --> 00:02:36.730
it a drug company producing the material
 

00:02:36.730 --> 00:02:37.830
it a drug company producing the material
sometimes it's actually not bad

00:02:37.830 --> 00:02:37.840
sometimes it's actually not bad
 

00:02:37.840 --> 00:02:39.750
sometimes it's actually not bad
information but very often it's all

00:02:39.750 --> 00:02:39.760
information but very often it's all
 

00:02:39.760 --> 00:02:42.500
information but very often it's all
about minimizing the harms the risks and

00:02:42.500 --> 00:02:42.510
about minimizing the harms the risks and
 

00:02:42.510 --> 00:02:45.000
about minimizing the harms the risks and
maximizing the benefits and exaggerating

00:02:45.000 --> 00:02:45.010
maximizing the benefits and exaggerating
 

00:02:45.010 --> 00:02:47.069
maximizing the benefits and exaggerating
the benefits so you have to look deeper

00:02:47.069 --> 00:02:47.079
the benefits so you have to look deeper
 

00:02:47.079 --> 00:02:51.119
the benefits so you have to look deeper
beyond the sort of twenty second bullet

00:02:51.119 --> 00:02:51.129
beyond the sort of twenty second bullet
 

00:02:51.129 --> 00:02:53.640
beyond the sort of twenty second bullet
points you see even physicians are

00:02:53.640 --> 00:02:53.650
points you see even physicians are
 

00:02:53.650 --> 00:02:55.680
points you see even physicians are
inappropriately in influenced by

00:02:55.680 --> 00:02:55.690
inappropriately in influenced by
 

00:02:55.690 --> 00:02:57.720
inappropriately in influenced by
pharmaceutical advertising and

00:02:57.720 --> 00:02:57.730
pharmaceutical advertising and
 

00:02:57.730 --> 00:02:59.849
pharmaceutical advertising and
educational programming so you can't

00:02:59.849 --> 00:02:59.859
educational programming so you can't
 

00:02:59.859 --> 00:03:01.589
educational programming so you can't
always depend on your physician one

00:03:01.589 --> 00:03:01.599
always depend on your physician one
 

00:03:01.599 --> 00:03:03.390
always depend on your physician one
excellent example is the overuse of

00:03:03.390 --> 00:03:03.400
excellent example is the overuse of
 

00:03:03.400 --> 00:03:05.550
excellent example is the overuse of
statin drugs in women for primary

00:03:05.550 --> 00:03:05.560
statin drugs in women for primary
 

00:03:05.560 --> 00:03:08.970
statin drugs in women for primary
prevention of heart attacks things like

00:03:08.970 --> 00:03:08.980
prevention of heart attacks things like
 

00:03:08.980 --> 00:03:11.129
prevention of heart attacks things like
that that for secondary prevention we

00:03:11.129 --> 00:03:11.139
that that for secondary prevention we
 

00:03:11.139 --> 00:03:13.589
that that for secondary prevention we
have very good studies that show benefit

00:03:13.589 --> 00:03:13.599
have very good studies that show benefit
 

00:03:13.599 --> 00:03:15.270
have very good studies that show benefit
for women but not for primary prevention

00:03:15.270 --> 00:03:15.280
for women but not for primary prevention
 

00:03:15.280 --> 00:03:17.400
for women but not for primary prevention
so now women who simply have an elevated

00:03:17.400 --> 00:03:17.410
so now women who simply have an elevated
 

00:03:17.410 --> 00:03:19.710
so now women who simply have an elevated
cholesterol level no other problems are

00:03:19.710 --> 00:03:19.720
cholesterol level no other problems are
 

00:03:19.720 --> 00:03:22.080
cholesterol level no other problems are
told to go on statin drugs when in fact

00:03:22.080 --> 00:03:22.090
told to go on statin drugs when in fact
 

00:03:22.090 --> 00:03:24.930
told to go on statin drugs when in fact
in many cases is they stand to be hurt

00:03:24.930 --> 00:03:24.940
in many cases is they stand to be hurt
 

00:03:24.940 --> 00:03:27.240
in many cases is they stand to be hurt
more than helped and getting it the kind

00:03:27.240 --> 00:03:27.250
more than helped and getting it the kind
 

00:03:27.250 --> 00:03:29.280
more than helped and getting it the kind
of data that evidence-based folks have

00:03:29.280 --> 00:03:29.290
of data that evidence-based folks have
 

00:03:29.290 --> 00:03:31.199
of data that evidence-based folks have
produced those without conflicts of

00:03:31.199 --> 00:03:31.209
produced those without conflicts of
 

00:03:31.209 --> 00:03:32.670
produced those without conflicts of
interest these are physicians and

00:03:32.670 --> 00:03:32.680
interest these are physicians and
 

00:03:32.680 --> 00:03:34.229
interest these are physicians and
researchers whom we try to work closely

00:03:34.229 --> 00:03:34.239
researchers whom we try to work closely
 

00:03:34.239 --> 00:03:36.449
researchers whom we try to work closely
with getting at that information is

00:03:36.449 --> 00:03:36.459
with getting at that information is
 

00:03:36.459 --> 00:03:38.699
with getting at that information is
often hard because it doesn't make it

00:03:38.699 --> 00:03:38.709
often hard because it doesn't make it
 

00:03:38.709 --> 00:03:40.470
often hard because it doesn't make it
onto television it's certainly in the

00:03:40.470 --> 00:03:40.480
onto television it's certainly in the
 

00:03:40.480 --> 00:03:42.420
onto television it's certainly in the
medical literature but there's no PR

00:03:42.420 --> 00:03:42.430
medical literature but there's no PR
 

00:03:42.430 --> 00:03:44.009
medical literature but there's no PR
company getting that out to you the

00:03:44.009 --> 00:03:44.019
company getting that out to you the
 

00:03:44.019 --> 00:03:46.530
company getting that out to you the
public so we are a voice for those

00:03:46.530 --> 00:03:46.540
public so we are a voice for those
 

00:03:46.540 --> 00:03:50.490
public so we are a voice for those
sources of uncompromised information we

00:03:50.490 --> 00:03:50.500
sources of uncompromised information we
 

00:03:50.500 --> 00:03:51.930
sources of uncompromised information we
make sure it's in lei Leng gwa jande we

00:03:51.930 --> 00:03:51.940
make sure it's in lei Leng gwa jande we
 

00:03:51.940 --> 00:03:53.729
make sure it's in lei Leng gwa jande we
get it out in our website through our

00:03:53.729 --> 00:03:53.739
get it out in our website through our
 

00:03:53.739 --> 00:03:55.830
get it out in our website through our
blog we have a very popular blog our

00:03:55.830 --> 00:03:55.840
blog we have a very popular blog our
 

00:03:55.840 --> 00:03:57.599
blog we have a very popular blog our
bodies our blog that many women read

00:03:57.599 --> 00:03:57.609
bodies our blog that many women read
 

00:03:57.609 --> 00:04:01.020
bodies our blog that many women read
every day and we send our readers and

00:04:01.020 --> 00:04:01.030
every day and we send our readers and
 

00:04:01.030 --> 00:04:03.149
every day and we send our readers and
our hua our listeners to these other

00:04:03.149 --> 00:04:03.159
our hua our listeners to these other
 

00:04:03.159 --> 00:04:05.819
our hua our listeners to these other
sources of more dependable information

00:04:05.819 --> 00:04:05.829
sources of more dependable information
 

00:04:05.829 --> 00:04:07.589
sources of more dependable information
where there aren't conflicts of interest

00:04:07.589 --> 00:04:07.599
where there aren't conflicts of interest
 

00:04:07.599 --> 00:04:09.689
where there aren't conflicts of interest
and that's something every single woman

00:04:09.689 --> 00:04:09.699
and that's something every single woman
 

00:04:09.699 --> 00:04:11.909
and that's something every single woman
has to think about and be concerned

00:04:11.909 --> 00:04:11.919
has to think about and be concerned
 

00:04:11.919 --> 00:04:13.530
has to think about and be concerned
about is where is the conflict of

00:04:13.530 --> 00:04:13.540
about is where is the conflict of
 

00:04:13.540 --> 00:04:16.140
about is where is the conflict of
interest here am I getting information

00:04:16.140 --> 00:04:16.150
interest here am I getting information
 

00:04:16.150 --> 00:04:19.020
interest here am I getting information
that is truly not tainted by commercial

00:04:19.020 --> 00:04:19.030
that is truly not tainted by commercial
 

00:04:19.030 --> 00:04:21.209
that is truly not tainted by commercial
interests another excellent example of

00:04:21.209 --> 00:04:21.219
interests another excellent example of
 

00:04:21.219 --> 00:04:23.070
interests another excellent example of
where we saw this was in the recent new

00:04:23.070 --> 00:04:23.080
where we saw this was in the recent new
 

00:04:23.080 --> 00:04:24.810
where we saw this was in the recent new
mammography guidelines produced

00:04:24.810 --> 00:04:24.820
mammography guidelines produced
 

00:04:24.820 --> 00:04:26.730
mammography guidelines produced
the US Preventive Services Task Force

00:04:26.730 --> 00:04:26.740
the US Preventive Services Task Force
 

00:04:26.740 --> 00:04:29.940
the US Preventive Services Task Force
these are excellent guidelines those who

00:04:29.940 --> 00:04:29.950
these are excellent guidelines those who
 

00:04:29.950 --> 00:04:32.130
these are excellent guidelines those who
have a lot to lose if women under 50

00:04:32.130 --> 00:04:32.140
have a lot to lose if women under 50
 

00:04:32.140 --> 00:04:35.070
have a lot to lose if women under 50
don't get routine mammograms or if women

00:04:35.070 --> 00:04:35.080
don't get routine mammograms or if women
 

00:04:35.080 --> 00:04:36.660
don't get routine mammograms or if women
over 50 do it maybe a little less

00:04:36.660 --> 00:04:36.670
over 50 do it maybe a little less
 

00:04:36.670 --> 00:04:39.480
over 50 do it maybe a little less
frequently based upon their profile they

00:04:39.480 --> 00:04:39.490
frequently based upon their profile they
 

00:04:39.490 --> 00:04:41.760
frequently based upon their profile they
have a lot to lose those are the ones

00:04:41.760 --> 00:04:41.770
have a lot to lose those are the ones
 

00:04:41.770 --> 00:04:43.830
have a lot to lose those are the ones
critiquing this not the evidence-based

00:04:43.830 --> 00:04:43.840
critiquing this not the evidence-based
 

00:04:43.840 --> 00:04:45.990
critiquing this not the evidence-based
folks those without conflicts of

00:04:45.990 --> 00:04:46.000
folks those without conflicts of
 

00:04:46.000 --> 00:04:47.640
folks those without conflicts of
interest and there are many of them out

00:04:47.640 --> 00:04:47.650
interest and there are many of them out
 

00:04:47.650 --> 00:04:49.380
interest and there are many of them out
there have reviewed what the preventive

00:04:49.380 --> 00:04:49.390
there have reviewed what the preventive
 

00:04:49.390 --> 00:04:51.120
there have reviewed what the preventive
services task force is produced and

00:04:51.120 --> 00:04:51.130
services task force is produced and
 

00:04:51.130 --> 00:04:53.010
services task force is produced and
certainly our experts those for the

00:04:53.010 --> 00:04:53.020
certainly our experts those for the
 

00:04:53.020 --> 00:04:54.420
certainly our experts those for the
National Women's Health Network and

00:04:54.420 --> 00:04:54.430
National Women's Health Network and
 

00:04:54.430 --> 00:04:56.700
National Women's Health Network and
several other wonderful organizations

00:04:56.700 --> 00:04:56.710
several other wonderful organizations
 

00:04:56.710 --> 00:04:58.740
several other wonderful organizations
have gone to back and said these are

00:04:58.740 --> 00:04:58.750
have gone to back and said these are
 

00:04:58.750 --> 00:05:00.360
have gone to back and said these are
excellent guidelines we should be

00:05:00.360 --> 00:05:00.370
excellent guidelines we should be
 

00:05:00.370 --> 00:05:02.250
excellent guidelines we should be
following them it's not about denying

00:05:02.250 --> 00:05:02.260
following them it's not about denying
 

00:05:02.260 --> 00:05:03.990
following them it's not about denying
women care and by the way everyone

00:05:03.990 --> 00:05:04.000
women care and by the way everyone
 

00:05:04.000 --> 00:05:05.670
women care and by the way everyone
should understand that mammography is a

00:05:05.670 --> 00:05:05.680
should understand that mammography is a
 

00:05:05.680 --> 00:05:07.830
should understand that mammography is a
relatively weak tool for screening we

00:05:07.830 --> 00:05:07.840
relatively weak tool for screening we
 

00:05:07.840 --> 00:05:09.570
relatively weak tool for screening we
need better tools in the area of breast

00:05:09.570 --> 00:05:09.580
need better tools in the area of breast
 

00:05:09.580 --> 00:05:11.940
need better tools in the area of breast
cancer it's not like Pap tests where we

00:05:11.940 --> 00:05:11.950
cancer it's not like Pap tests where we
 

00:05:11.950 --> 00:05:13.950
cancer it's not like Pap tests where we
have an excellent screening tool for

00:05:13.950 --> 00:05:13.960
have an excellent screening tool for
 

00:05:13.960 --> 00:05:15.900
have an excellent screening tool for
cervical cancer we're not doing so well

00:05:15.900 --> 00:05:15.910
cervical cancer we're not doing so well
 

00:05:15.910 --> 00:05:18.420
cervical cancer we're not doing so well
in the area of breast cancer so there's

00:05:18.420 --> 00:05:18.430
in the area of breast cancer so there's
 

00:05:18.430 --> 00:05:20.490
in the area of breast cancer so there's
an area where you would have seen the

00:05:20.490 --> 00:05:20.500
an area where you would have seen the
 

00:05:20.500 --> 00:05:21.990
an area where you would have seen the
American Cancer Society you would have

00:05:21.990 --> 00:05:22.000
American Cancer Society you would have
 

00:05:22.000 --> 00:05:24.420
American Cancer Society you would have
seen some prominent folks in breast

00:05:24.420 --> 00:05:24.430
seen some prominent folks in breast
 

00:05:24.430 --> 00:05:26.940
seen some prominent folks in breast
cancer treatment and people who have

00:05:26.940 --> 00:05:26.950
cancer treatment and people who have
 

00:05:26.950 --> 00:05:29.550
cancer treatment and people who have
interest some in some in cases in the

00:05:29.550 --> 00:05:29.560
interest some in some in cases in the
 

00:05:29.560 --> 00:05:31.410
interest some in some in cases in the
equipment the mammography equipment

00:05:31.410 --> 00:05:31.420
equipment the mammography equipment
 

00:05:31.420 --> 00:05:33.330
equipment the mammography equipment
that's being sold they have financial

00:05:33.330 --> 00:05:33.340
that's being sold they have financial
 

00:05:33.340 --> 00:05:34.620
that's being sold they have financial
interests in it so of course they don't

00:05:34.620 --> 00:05:34.630
interests in it so of course they don't
 

00:05:34.630 --> 00:05:36.570
interests in it so of course they don't
want to see the business go down these

00:05:36.570 --> 00:05:36.580
want to see the business go down these
 

00:05:36.580 --> 00:05:38.220
want to see the business go down these
are things the public doesn't see very

00:05:38.220 --> 00:05:38.230
are things the public doesn't see very
 

00:05:38.230 --> 00:05:40.350
are things the public doesn't see very
easily

